Title: Associate Director
Company: Revolution Medicines Inc.
Location: Los Altos, California, United States
Anupama D. Ravi, PhD, associate director at Revolution Medicines Inc., has been recognized by Marquis Who’s Who Top Scientists for dedication, achievements, and leadership in biotechnology.
With nearly two and a half decades of experience to her credit, Dr. Ravi has built a successful career in biotechnology, specializing in biomarker operations. Since 2022, she has excelled as associate director at Revolution Medicines Inc., where she helps scientists determine which biomarkers to test in order to assess a medication’s impact and facilitates the transfer of data from clinical sites to the testing lab. Revolution Medicines Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing precision therapies targeting RAS-addicted cancers, which account for approximately 30% of all newly diagnosed cancers. She has also been a science blogger at NaTech4Kids.org since 2020 and the founder of NaTech4Kids, established in 2011. NaTech4Kids was created to simplify complex scientific concepts and make them accessible and relatable for everyone. Drawing on her experience working in premier research labs and biotech companies, she and her team share their knowledge through blog articles, aiming to help the wider community better understand the natural world through a scientific lens.
Dr. Ravi’s experience includes serving as the clinical biomarkers and diagnostics lead at Amgen from 2021 to 2022, manager at BeiGene from 2019 to 2020, and biomarker operations project manager at Genentech from 2015 to 2019. She has also held positions as project manager at Clinovo from 2014 to 2015, consultant at Vital Connect Inc. in 2013, project manager at Aurigene from 2009 to 2010, business development specialist at Evolva Biotech from 2006 to 2008, microinjectionist at the University of Cambridge from 2005 to 2006, and junior research fellow at the National Centre for Biological Sciences from 2000 to 2001. In addition, she dedicates her time to the Nature Journal Review Group and is a fellow of the Cambridge Commonwealth Trust. Laying a solid educational foundation, Dr. Ravi earned a Bachelor of Science in zoology, chemistry, and environmental science from Bangalore University in 1997, a Master of Science in applied genetics from Bangalore University in 2000, and a PhD in genetics at the University of Cambridge in 2005. Additionally, she holds a certificate in clinical development, good clinical practice, good laboratory practice, good manufacturing practice, and regulatory affairs from San Francisco State University, and is a recipient of the Cambridge Commonwealth Trust Scholarship.
Reflecting on her path, Dr. Ravi recalls her eagerness to leave academia after completing her PhD, which led her to venture into the business world by taking on a role in startup development. This position allowed her to stay connected with her scientific roots, as much of her time was spent writing research proposals. She then transitioned into project management, successfully applying her scientific expertise to a new field. Her adaptability and drive ultimately paved the way for her specialization in biomarkers, where she found the perfect blend of her passion for science and a dynamic. She attributes her success to hard work and the sacrifices her parents made to provide a proper education for her and her brother. In the coming years, she aims to build a revolutionary medicine department with a strong team and a well-functioning biomarker operation. Additionally, she aspires to make scientific concepts more accessible to young children to help foster a love for science from an early age.
For more information, please visit:
Contact Dr. Ravi:
